Ireland
--:--IST
Recruiting Not applicable

Integrated Echocardiography and Chest Ultrasound Assessment of Lung Recruitment in Preterm Infants

NCT05726578 · tracked via the Priya Life Science Egypt tracker
Phase
Not applicable
Started
2024-07-01
Last updated
2025-05-28

Condition(s) studied

Ventilator LungEchocardiographyChest UltrasoundHigh Frequency VentilationLung Recruitment

Investigational drug(s) / intervention(s)

Lung recruitment

Lung recruitment: establishment of lung recruitment using high frequency ventilation and assessment with chest ultrasound and echocardiography

Study summary

The primary aim of this work is to evaluate the role of high frequency oscillatory ventilation (HFOV) in recruitment of lung in preterm newborns 32 to 37 weeks gestational age with moderate to severe respiratory distress. The secondary aim is to evaluate the role of chest ultrasound in monitoring of lung recruitment in comparison to routine chest x ray in those babies. Also cardiac hemodynamics will be assesed using functional echocardiography.

Eligibility

Sex
ALL
Min age
1 Hour
Max age
3 Days
Healthy volunteers
No
Inclusion Criteria: * Infants will be enrolled if they are 32 to 37 weeks of gestational age, have respiratory distress (RD) in the first 24 h of life, intubated and have invasive respiratory support using HFOV. Signs of RD are tachypnea (respiratory rate \> 60/min), grunting, nasal flaring, chest retraction, and need of oxygen supplementation or other respiratory support. Exclusion Criteria: 1. Known major congenital anomalies including congenital heart diseases. 2. Fetal hydrops. 3. Babies with congenital heart diseases

Primary outcome measure(s)

  • chest US — first 3 days after birth
    A mobile device (PHILIPS ® HD11 XE) with a 10-MHz linear probe will be used for chest ultrasound the 12 lung zones will be assessed regarding 1. presence Of A lines, B-lines or C-profile 2. presence or absence of pleural sliding
  • Superior Vena Cava flow in ml/kg/min — first 3 days of life
    Superior Vena Cava (SVC) Blood Flow using functional echocardiography
  • estimated pulmonary artery pressure in mmHg — first 3 days of life
    Pulmonary artery pressure (PAP) will be assessed by measuring tricuspid valve regurgitation peak velocity: this will be measured in apical 4 chamber view, with continous wave Doppler using modified Bernoulli equation. Systolic pulmonary artery pressure is equivalent to right ventricular systolic pressure in absence of outflow obstruction. Systolic Pulmonary Artery Pressure (SPAP) = Right Ventricular Systolic Pressure = 4x TR2 + Right Atrial Pressure (RAP), with RAP= 3-5 mmHg.

Trial sites (2)

FacilityCityRegionStatus
Marwa Mohamed Farag Alexandria Egypt Recruiting
Neonatal Intensive Care Unit (NICU) of Alexandria University Maternity Hospital. Alexandria Egypt Not Yet Recruiting

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05726578 on ClinicalTrials.gov ↗ ← All trials in Egypt